{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:40:06Z","timestamp":1772156406386,"version":"3.50.1"},"posted":{"date-parts":[[2024,5,28]]},"group-title":"Microbiology","reference-count":45,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Gonorrhea, which is caused by\n                  <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                  , is the second most reported sexually transmitted infection worldwide. The increasing appearance of isolates that are resistant to approved therapeutics raises the concern that gonorrhea may become untreatable. Here, we serendipitously identified oxydifficidin as a potent\n                  <jats:italic>N. gonorrhoeae<\/jats:italic>\n                  antibiotic through the observation of a\n                  <jats:italic>Bacillus amyloliquefaciens<\/jats:italic>\n                  contaminant in a lawn of\n                  <jats:italic>N. gonorrhoeae<\/jats:italic>\n                  . Oxydifficidin is active against both wild- type and multidrug-resistant\n                  <jats:italic>N. gonorrhoeae<\/jats:italic>\n                  . It\u2019s potent activity results from a combination of DedA- assisted uptake into the cytoplasm and the presence of an oxydifficidin-sensitive ribosomal protein L7\/L12 (RplL). Our data indicates that oxydifficidin binds to the ribosome at a site that is distinct from other antibiotics and that L7\/L12 is uniquely associated with its mode of action. This study opens a potential new avenue for addressing antibiotic resistant gonorrhea and underscores the possibility of identifying overlooked natural products from cultured bacteria, particularly those with activity against previously understudied pathogens.\n                <\/jats:p>","DOI":"10.1101\/2024.05.27.596031","type":"posted-content","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:40:10Z","timestamp":1716921610000},"source":"Crossref","is-referenced-by-count":1,"title":["Oxydifficidin, a potent\n                  <i>Neisseria gonorrhoeae<\/i>\n                  antibiotic due to DedA assisted uptake and ribosomal protein RplL sensitivity"],"prefix":"10.64898","author":[{"given":"Jingbo","family":"Kan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozen","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda A.","family":"Ternei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Lemetre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan W.","family":"Maclntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Biais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5967-8586","authenticated-orcid":false,"given":"Sean F.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024092904300542000_2024.05.27.596031v2.1","unstructured":"G. World Health Organization, Prevention and control of sexually transmitted infections (STIs) in the era of oral pre- exposure prophylaxis (PrEP) for HIV. Licence: CC BY-NC-SA 3.0 IGO. (2019)."},{"key":"2024092904300542000_2024.05.27.596031v2.2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6950a6"},{"key":"2024092904300542000_2024.05.27.596031v2.3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"2024092904300542000_2024.05.27.596031v2.4","doi-asserted-by":"publisher","DOI":"10.3201\/eid1701.100397"},{"key":"2024092904300542000_2024.05.27.596031v2.5","doi-asserted-by":"crossref","unstructured":"M. Day et al., Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022. Euro Surveill 27 (2022).","DOI":"10.2807\/1560-7917.ES.2022.27.46.2200803"},{"key":"2024092904300542000_2024.05.27.596031v2.6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13756-020-00805-7","article-title":"Azithromycin resistant gonococci: a literature review","volume":"9","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"2024092904300542000_2024.05.27.596031v2.7","doi-asserted-by":"crossref","first-page":"e0168821","DOI":"10.1128\/aac.01688-21","article-title":"Increasing Azithromycin Resistance in Neisseria gonorrhoeae Due to NG-MAST 12302 Clonal Spread in Canada, 2015 to 2018","volume":"66","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2024092904300542000_2024.05.27.596031v2.8","doi-asserted-by":"crossref","unstructured":"B. Shaskolskiy , I. Kandinov , E. Dementieva , D. Gryadunov , Antibiotic Resistance in Neisseria gonorrhoeae: Challenges in Research and Treatment. Microorganisms 10 (2022).","DOI":"10.3390\/microorganisms10091699"},{"key":"2024092904300542000_2024.05.27.596031v2.9","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198427060-00001"},{"key":"2024092904300542000_2024.05.27.596031v2.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800173-8.00001-5","article-title":"Azithromycin","volume":"39","year":"2014","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"2024092904300542000_2024.05.27.596031v2.11","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.9b01285"},{"key":"2024092904300542000_2024.05.27.596031v2.12","doi-asserted-by":"publisher","DOI":"10.3390\/metabo2020303"},{"key":"2024092904300542000_2024.05.27.596031v2.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.056"},{"key":"2024092904300542000_2024.05.27.596031v2.14","first-page":"1682","article-title":"Difficidin and oxydifficidin: novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis","volume":"40","year":"1987","journal-title":"II. Isolation and physico-chemical characterization. J Antibiot (Tokyo"},{"key":"2024092904300542000_2024.05.27.596031v2.15","first-page":"1677","article-title":"Difficidin and oxydifficidin: novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis","volume":"40","year":"1987","journal-title":"I. Production, taxonomy and antibacterial activity. J Antibiot (Tokyo"},{"key":"2024092904300542000_2024.05.27.596031v2.16","doi-asserted-by":"crossref","unstructured":"M. S. Ngalimat et al., A Review on the Biotechnological Applications of the Operational Group Bacillus amyloliquefaciens. Microorganisms 9 (2021).","DOI":"10.3390\/microorganisms9030614"},{"key":"2024092904300542000_2024.05.27.596031v2.17","doi-asserted-by":"publisher","DOI":"10.1128\/JB.186.4.1084-1096.2004"},{"key":"2024092904300542000_2024.05.27.596031v2.18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003495-198529040-00001","article-title":"Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"29","year":"1985","journal-title":"Drugs"},{"key":"2024092904300542000_2024.05.27.596031v2.19","doi-asserted-by":"crossref","unstructured":"J. J. Petkowski , W. Bains , S. Seager , Natural Products Containing \u2019Rare\u2019 Organophosphorus Functional Groups. Molecules 24 (2019).","DOI":"10.3390\/molecules24050866"},{"key":"2024092904300542000_2024.05.27.596031v2.20","doi-asserted-by":"crossref","first-page":"42204","DOI":"10.1039\/C9RA08299A","article-title":"The intriguing biology and chemistry of fosfomycin: the only marketed phosphonate antibiotic","volume":"9","year":"2019","journal-title":"RSC Adv"},{"key":"2024092904300542000_2024.05.27.596031v2.21","doi-asserted-by":"crossref","first-page":"e0073421","DOI":"10.1128\/MRA.00734-21","article-title":"Complete Genome Sequences of Seven Neisseria gonorrhoeae Clinical Isolates from Mucosal and Disseminated Gonococcal Infections","volume":"10","year":"2021","journal-title":"Microbiol Resour Announc"},{"key":"2024092904300542000_2024.05.27.596031v2.22","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01006-12"},{"key":"2024092904300542000_2024.05.27.596031v2.23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41586-022-05569-1","article-title":"Undecaprenyl phosphate translocases confer conditional microbial fitness","volume":"613","year":"2023","journal-title":"Nature"},{"key":"2024092904300542000_2024.05.27.596031v2.24","doi-asserted-by":"crossref","unstructured":"I. J. Roney , D. Z. Rudner , The DedA superfamily member PetA is required for the transbilayer distribution of phosphatidylethanolamine in bacterial membranes. P Natl Acad Sci USA 120 (2023).","DOI":"10.1073\/pnas.2301979120"},{"key":"2024092904300542000_2024.05.27.596031v2.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.05.006"},{"key":"2024092904300542000_2024.05.27.596031v2.26","doi-asserted-by":"crossref","unstructured":"Y. E. Li et al., TMEM41B and VMP1 are scramblases and regulate the distribution of cholesterol and phosphatidylserine. J Cell Biol 220 (2021).","DOI":"10.1083\/jcb.202103105"},{"key":"2024092904300542000_2024.05.27.596031v2.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.04.015"},{"key":"2024092904300542000_2024.05.27.596031v2.28","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14067"},{"key":"2024092904300542000_2024.05.27.596031v2.29","first-page":"1692","article-title":"Difficidin and oxydifficidin: novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis","volume":"40","year":"1987","journal-title":"III. Mode of action of difficidin. J Antibiot (Tokyo"},{"key":"2024092904300542000_2024.05.27.596031v2.30","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-062917-011942"},{"key":"2024092904300542000_2024.05.27.596031v2.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-023-01047-y"},{"key":"2024092904300542000_2024.05.27.596031v2.32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fmolb.2018.00048","article-title":"The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics","volume":"5","year":"2018","journal-title":"Front Mol Biosci"},{"key":"2024092904300542000_2024.05.27.596031v2.33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1604790113"},{"key":"2024092904300542000_2024.05.27.596031v2.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.01.009"},{"key":"2024092904300542000_2024.05.27.596031v2.35","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/med.21780","article-title":"Ribosome-targeting antibacterial agents: Advances, challenges, and opportunities","volume":"41","year":"2021","journal-title":"Med Res Rev"},{"key":"2024092904300542000_2024.05.27.596031v2.36","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1265"},{"key":"2024092904300542000_2024.05.27.596031v2.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1995.tb02420.x"},{"key":"2024092904300542000_2024.05.27.596031v2.38","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKZ926"},{"key":"2024092904300542000_2024.05.27.596031v2.39","doi-asserted-by":"publisher","DOI":"10.1101\/2023.01.04.522824"},{"key":"2024092904300542000_2024.05.27.596031v2.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34630-w"},{"key":"2024092904300542000_2024.05.27.596031v2.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009490"},{"key":"2024092904300542000_2024.05.27.596031v2.42","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.65.2773"},{"key":"2024092904300542000_2024.05.27.596031v2.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2010.10.013"},{"key":"2024092904300542000_2024.05.27.596031v2.44","unstructured":"J. P. Dillard , Genetic Manipulation of Neisseria gonorrhoeae. Curr Protoc Microbiol Chapter 4, Unit4A 2 (2011)."},{"key":"2024092904300542000_2024.05.27.596031v2.45","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-8685-9_6"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.05.27.596031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:29:06Z","timestamp":1768458546000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.05.27.596031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1101\/2024.05.27.596031","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.7554\/elife.99281.3","asserted-by":"subject"},{"id-type":"doi","id":"10.7554\/eLife.99281.3","asserted-by":"object"}],"has-version":[{"id-type":"doi","id":"10.7554\/eLife.99281.1","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.99281.2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2024,5,28]]},"subtype":"preprint"}}